Ganesan Vithiya, Ponnusamy Shunmuga Sundaram, Sundaramurthy Raja
Velammal Medical College Hospital and Research Institute,Microbiology and Interventional Cardiology,Velammal Village,Tuticorin Ring Road,Anuppanadi,Madurai,TN,India.
Cardiol Young. 2017 Oct;27(8):1481-1487. doi: 10.1017/S1047951117000506.
The aims of this article were to review the published literature on fungal endocarditis in children and to discuss the aetiology and diagnosis, with emphasis on non-invasive methods and various treatment regimes.
We systematically reviewed published cases and case series of fungal endocarditis in children. We searched the literature, including PubMed and individual references for publications of original articles, single cases, or case series of paediatric fungal endocarditis, with the following keywords: "fungal endocarditis", "neonates", "infants", "child", and "cardiac vegetation".
There have been 192 documented cases of fungal endocarditis in paediatrics. The highest number of cases was reported in infants (93/192, 48%) including 60 in neonates. Of the neonatal cases, 57 were premature with a median gestational age of 27 weeks and median birth weight of 860 g. Overall, 120 yeast - fungus that grows as a single cell - infections and 43 mould - fungus that grows in multicellular filaments, hyphae - infections were reported. With increasing age, there was an increased infection rate with moulds. All the yeast infections were detected by blood culture. In cases with mould infection, diagnosis was mainly established by culture or histology of emboli or infected valves after invasive surgical procedures. There have been a few recent cases of successful early diagnosis by non-invasive methods such as blood polymerase chain reaction (PCR) for moulds. The overall mortality for paediatric fungal endocarditis was 56.25%. The most important cause of death was cardiac complications due to heart failure. Among the various treatment regimens used, none of them was significantly associated with better outcome.
Non-invasive methods such as PCR tests can be used to improve the chances of detecting and identifying the aetiological agent in a timely manner. Delays in the diagnosis of these infections may result in high mortality and morbidity. No significant difference was noted between combined surgical and medical therapy over exclusively combined medical therapy.
本文旨在回顾已发表的关于儿童真菌性心内膜炎的文献,并讨论其病因及诊断,重点关注非侵入性方法和各种治疗方案。
我们系统回顾了已发表的儿童真菌性心内膜炎病例及病例系列。我们检索了文献,包括PubMed及个别参考文献,以查找有关小儿真菌性心内膜炎的原始文章、单个病例或病例系列的出版物,检索关键词如下:“真菌性心内膜炎”、“新生儿”、“婴儿”、“儿童”及“心脏赘生物”。
儿科真菌性心内膜炎有192例文献记载病例。婴儿病例数最多(93/192,48%),其中新生儿60例。新生儿病例中,57例为早产儿,中位胎龄27周,中位出生体重860克。总体而言,报告了120例酵母菌感染(酵母菌为单细胞生长的真菌)和43例霉菌感染(霉菌为多细胞丝状、菌丝状生长的真菌)。随着年龄增长,霉菌感染率上升。所有酵母菌感染均通过血培养检测到。在霉菌感染病例中,诊断主要通过侵入性手术后栓子或感染瓣膜的培养或组织学检查确立。近期有少数病例通过非侵入性方法如血液聚合酶链反应(PCR)检测霉菌实现了早期成功诊断。儿科真菌性心内膜炎的总体死亡率为56.25%。死亡的最重要原因是心力衰竭导致的心脏并发症。在使用的各种治疗方案中,没有一种与更好的预后显著相关。
PCR检测等非侵入性方法可用于提高及时检测和鉴定病原体的几率。这些感染的诊断延迟可能导致高死亡率和高发病率。联合手术和药物治疗与单纯联合药物治疗之间未发现显著差异。